INCY Incyte
$112.73 -1.23%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-1.23%
YTD
+29.30%
P/E
14.62
P/B
3.75
ROE
29.6%
Div yield
—
Beta
0.43
Market cap
$23.6B
RSI (14)
30
Next earnings
Oct 26, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$114.13
Close
$112.73
VWAP (n/a)
—
Day high
$114.97
Day low
$111.67
Volume
2.5M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
Yahoo Finance · Oct 1
INCY or TECH: Which Is the Better Value Stock Right Now?
Yahoo Finance · Sep 30
Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment
Yahoo Finance · Sep 28
INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill
Yahoo Finance · Sep 25
Incyte (INCY) Heads To EADV With New Skin Disease Trial Data
Yahoo Finance · Sep 24
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
Yahoo Finance · Sep 23
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 31, 2026 View → 10-Q Jul 28, 2026 View → 8-K Jul 28, 2026 View → 8-K Jul 6, 2026 View → 8-K Jun 22, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell INCY. Try it in the Lab to size a position and see the risk.